Inclusion and exclusion criteria for the presented series of patients treated with p64
| Criteria for the p64 Treatment and Analysis in this Series |
|---|
| Inclusion |
| Intracranial saccular sidewall aneurysm as treatment target |
| Aneurysms unruptured or at least not in the acute phase after rupture |
| Extra- or intradural symptomatic aneurysm |
| Asymptomatic intradural aneurysms, thus carrying a potential risk of intracranial rupture |
| Anticipated difficulty of coil or clip treatment (eg, complex aneurysm morphology, wide neck, dome-to-neck ratio of <1.2, small size, difficult surgical access) |
| No previous treatment or any previous treatment directed at the aneurysm sac without complete occlusion of the aneurysm from circulation |
| No previous treatment to the parent vessel |
| An ability and willingness of the patient to take the necessary medication for midterm dual platelet function inhibition |
| Exclusion |
| Bifurcation-type aneurysm or fusiform vessel dilation as a treatment target |
| Implants other than p64 used |
| Aneurysm rupture ≤30 days prior to the p64 treatment |
| Extradural asymptomatic aneurysm |
| Anticipated ease or sufficiency of clip or coil treatment |
| Previous implantation of stents or flow diverters to the target-vessel segment |